A comparative study on the short‐term clinical outcomes of Da Vinci SP versus Da Vinci Xi for rectal cancer surgery
Wed Alshalawi, Chul Seung Lee, Byung Chul Kim, Seung‐Rim Han, In Kyeong Kim, Jung Hoon Bae, In Kyu Lee, Dosang Lee, Yoon Suk Lee
Abstract
PURPOSE: The Da Vinci SP robot system was recently introduced, but its safety and feasibility for rectal cancer compared with the currently used robot system have not been reported. METHODS: This was a single-centre retrospective study. Data from patients who underwent abdominal total mesorectal excision (TME) from October 2015 to October 2022 were analysed. After propensity score matching, the short-term outcomes were compared. RESULTS: A total of 56 patient data were analysed. Intersphincteric resection was more common in the SP group (7 cases (25%) vs. 0 case (0%), p = 0.001). The operation time was significantly shorter in SP (184 vs. 227.5 min, p < 0.0001), but the docking time was similar. The postoperative complications were similar. There were no differences in the postoperative pain score and length of hospital stay. CONCLUSION: The SP robotic system for abdominal TME has acceptable short-term and is safe and technically feasible.